President Trump Aims for $150 MFN Price Cap on GLP-1 Weight Loss Drugs

Drug Pricing Discrepancies

• 💡 The disparity in drug prices between countries is highlighted, with an example of a drug costing $130 in London versus $1,300 in New York.
• 🎯 The goal is to reduce the price of these drugs to approximately $150 per month for consumers in the US.

Favored Nations Policy

• 🤝 The "Favored Nations" policy is discussed as a mechanism to ensure the US pays the same price for drugs as other developed nations, aiming to end perceived global price gouging.
• 🇺🇸 This policy is presented as a way to correct historical disadvantages where the US has "been ripped off by the whole world."

GLP-1 Drug Negotiations

• 💉 The GLP-1 category of drugs, which includes popular weight loss medications like Ozempic, has not yet been subject to these negotiated prices.
• ⏳ While no specific timeline is given, it is expected that these negotiations will lead to price reductions relatively quickly.
• ✅ Negotiations will continue until the President is satisfied with the outcome.